[{"id":"ca3a151f-99fd-4284-98c7-f7bf4ae41c64","acronym":"","url":"https://clinicaltrials.gov/study/NCT05028296","created_at":"2021-08-31T14:53:01.481Z","updated_at":"2024-07-02T16:36:25.323Z","phase":"","brief_title":"Novel Mucosal Sampling Technology for Gastric Neoplasia: Wide-area Trans-epithelial Gastric Sampling for the Detection of Premalignant Lesions and Early Gastric Cancer","source_id_and_acronym":"NCT05028296","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" MUC2","pipe":"","alterations":" ","tags":["MUC2"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 300","initiation":"Initiation: 01/01/2022","start_date":" 01/01/2022","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2021-08-31"}]